ESC Professional Premium Access

Effect of 1st line treatment on aortic inflammation as assessed by 18 FDG PET/CT in patients with Hodgkin and non-Hodgkin lymphoma

Congress Presentation

About the speaker

Doctor Dimitrios Terentes-Printzios

National & Kapodistrian University of Athens, Athens (Greece)
1 presentation
0 follower

6 more presentations in this session

Basal characteristics of the prospective spanish immunotherapy registry of cardiovascular toxicity: SIR-CVT

Speaker: Doctor E. Zatarain-Nicolas (Madrid, ES)


The prognostic significance of troponin level in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study)

Speaker: Doctor A. Kaura (London, GB)


COVID-19 and acute heart failure among patients with cancer

Speaker: Doctor M. Bergami (Bologna, IT)


Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up

Speaker: Doctor A. Daniele (Buenos Aires, AR)


Prognostic impact of coronary artery calcifications in patients with newly diagnosed prostate cancer

Speaker: Doctor N. Stoedkilde-Joergensen (Aarhus, DK)


Access the full session

Cardio-oncology 4

Speakers: Doctor D. Terentes-Printzios, Doctor E. Zatarain-Nicolas, Doctor A. Kaura, Doctor M. Bergami, Doctor A. Daniele...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb